graphic
News > Deals
Bayer in lead for crop biz
July 5, 2001: 7:27 p.m. ET

Company reportedly in prime spot to buy Aventis' $3B CropScience business
graphic
graphic graphic
graphic
NEW YORK (CNNfn) - Europe's No. 2 drug and chemical company Bayer AG is the most likely candidate to snag Franco-German firm Aventis SA's CropScience business, a published report said Thursday.

According to the Wall Street Journal digital edition, the deal for the business, valued at about $3 billion, is two weeks away and could still fall apart at any time. But the article said Bayer has the edge on BASF AG in the auction, which has been going on for months.

In November 2000, Aventis unveiled plans Wednesday to narrow its focus on pharmaceuticals by selling its slow-growing agricultural products unit.

The Aventis CropScience business – nearly one-quarter owned by Germany's Schering AG – has been hit by recent controversy over its StarLink genetically modified corn, which has been approved for only for animal feed but has been found in consumer foods.

Spokesmen for Bayer and Aventis could not be reached for comment. graphic

  RELATED STORIES

Bayer issues profit warning - June 27, 2001

Aventis gets drug boost - Mar. 2, 2001





graphic

© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.